All News

Americans confident about drug safety

Personalized medicine report issued by HHS

Study from AHRQ and FDA will examine cardiovascular risks of ADHD drugs.

A PhRMA-sponsored study claims Medicare Part D reduced expenses for beneficiaries who had no insurance prior to the program.

NACDS testifies to Senate on methamphetamine

Although FDA is not aware of significant health risks, the agency is concerned about some of the product's claims.

More than 70 pharmacy executives and representatives visited with members of Congress.

CIGNA launches new on-line Rx price quote tool

FDA approves expanded age range for FluMist influenza vaccine.

New dose of carisoprodol (Soma) is approved for MedPointe Pharmaceuticals

Raloxifene (Evista, Lilly) is approved for breast cancer

NACDS urges delay of tamper-resistant paper implementation deadlines

Intravenous injection of haloperidol (Haldol) may cause QT prolongation and torsades de pointes

FDA releases first issue of Drug Safety Newsletter

The Centers for Medicare and Medicaid Services answers questions about its new Medicaid tamper-resistant prescription pad rule

System Planning releases PharmaTrak, a system using barcodes or RFID tags for drug tracking through the pharmaceutical supply chain

Company recalling saline syringes

CVS Caremark receives DMEPOS accreditation

Humana is expanding two call centers in Arizona

Target offers free flavoring for liquid medications

FDA and Cephalon issue warning letters on Fentora use

NACDS Foundation to award scholarships to pharmacy students

Joint Commission wants feedback on medication management

CVS files complaint against Prasco for breach of contract

A regional group of pharmacy schools has formed in New England to promote training of preceptors

A 300-patient, randomized phase II study showed that weekly treatment of metastatic breast cancer with solvent-free, aluminum-bound nab-paclitaxel is better tolerated than standard first-line treatment with docetaxel.

Treatments suggested include probiotics coupled with fructooligosaccharides. zinc pyrithione products, glycemic support products, and homeopathic medicines.

A University of Texas study reveals that many pharmacies wait longer than 30 days for payment for Medicare Part D prescriptions.